source Post navigation A Simple Blood Test May Predict Cancer Risk in T2D – Medscape Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes | Eli Lilly and Company – Investors | Eli Lilly and Company